September 29, 2016 6:02 AM ET

Healthcare Equipment and Supplies

Company Overview of CardiacAssist, Inc.

Company Overview

CardiacAssist, Inc. operates as a medical device company that develops, manufactures, and markets novel medical devices to cardiologists and cardiac surgeons for improving the lives of heart failure patients worldwide. The company offers a temporary ventricular assist/circulatory support device for postcardiotomy cardiac failure issues; and TandemLung oxygenator, a medical device that acts as an artificial lung to infuse oxygen and remove carbon dioxide from the blood. It also provides a hydrodynamic centrifugal pump and a transseptal cannula for temporary left ventricular assist needs; and an electromechanical system. CardiacAssist, Inc. was formerly known as Cardiac Assist Technologies, In...

240 Alpha Drive

Pittsburgh, PA 15238

United States

Founded in 1996

Phone:

412-963-7770

Fax:

412-963-0800

Key Executives for CardiacAssist, Inc.

Chairman, Chief Executive Officer and President
Age: 90
Co-Founder and Director
Chief Financial Officer
Director of Engineering
Director of Clinical Education
Compensation as of Fiscal Year 2016.

CardiacAssist, Inc. Key Developments

CardiacAssist Receives FDA 510(k) Clearance for its TandemLung Oxygenator

CardiacAssist, Inc. announced that it has received 510(k) clearance from the U.S. Food and Drug Administration for its new TandemLung® oxygenator, a medical device that acts as an artificial lung to infuse oxygen and remove carbon dioxide from the blood. When paired with CardiacAssist's TandemHeart® blood pump, the TandemLung represents a leap forward in extracorporeal life support (ECLS) technology for patients in need of critical cardiopulmonary care. Every year in North America, more than 300,000 patients experience an acute cardiac or respiratory event that requires emergency intervention. However, historically only a small percentage of these patients have received advanced life support utilizing products like the TandemHeart and TandemLung, primarily due to the complexity of deploying existing technology to perform such procedures. The TandemLung oxygenator was developed to make ECLS faster and more accessible with a design optimized for simplicity and performance. Its low priming volume and patent-protected radial flow technology allow the device to be deployed quickly to protect patients from the negative effects of diminished cardiac or respiratory function.

Similar Private Companies By Industry

Company Name Region
.decimal, Inc. United States
20/20 GeneSystems, Inc. United States
20/20 Imaging LLC United States
21st Century Scientific, Inc. United States
21X Corporation United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact CardiacAssist, Inc., please visit www.tandemlife.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.